Permeon Biologics Inc Cambridge, MA - 02139

Permeon Biologics Inc is categorized under Commercial Medical Research in Cambridge, MA and active since 2009.

Permeon Biologics Inc was established in 2009, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 3254140 by the NAICS.

If you are seeking more information, feel free to contact Katherine Bowdish, President at the company’s single location by writing to 1 Kendall Square # B14203, Cambridge, Massachusetts MA 02139 or by phoning (617) 945-7780. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Permeon Biologics Inc
Contact Person: Katherine Bowdish, President
Address: 1 Kendall Square # B14203, Cambridge, Massachusetts 02139
Phone Number: (617) 945-7780
Website Address: permeonbio.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 3254140
Share This Business:

Permeon Biologics Inc was started in 2009 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 3254140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Katherine Bowdish, President for inquiries that concern Permeon Biologics Inc by calling the company number (617) 945-7780, as your correspondence is most welcome. Additionally, the physical location of the single location of Permeon Biologics Inc can be found at the coordinates 42.3631,-71.1033 as well as the street address 1 Kendall Square # B14203 in Cambridge, Massachusetts 02139.

For its online presence, you may visit Permeon Biologics Inc’s website at permeonbio.com and engage with its social media outlets through on Twitter and on Facebook.